Enhanced T cell suppression is directed toward sensitive circulating B cells in multiple myeloma

Robert T. Perri, Martin M. Oken, Neil Elliot Kay

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Multiple myeloma, a disorder typically accompanied by monoclonal immunoglobulin excess and hypogammaglobulinemia was evaluated to delineate the status of T cell regulation on malignant B cell proliferation. Intact T cells and T cell subsets previously noted by us to be suppressor (Tγ) and helper (T non-γ) were isolated from 10 controls and 10 myeloma patients. Various concentrations of control and patient T cell subsets were mixed with control and patient B cells and stimulated with PWM. T cell effect on B cell proliferation as measured by [3H]thymidine incorporation was then determined. Myeloma Tγ cells were more effective than control Tγ cells in suppressing control or myeloma B cell [3H]thymidine incorporation. Interestingly, myeloma B cells, when added to myeloma Tγ cells, were suppressed to a greater extent than were control B cells when mixed with a similar concentration of myeloma Tγ cells. These in vitro studies suggest a complexity of B and T cell abnormalities in multiple myeloma; first, the myeloma B cells are extremely sensitive to Tγ cell suppression, and second, myeloma Tγ cells have excessive suppressor capacity. It is yet unclear whether these results are associated with an immunoregulatory response to this malignancy or represent part of the basic disease process.

Original languageEnglish (US)
Pages (from-to)512-519
Number of pages8
JournalThe Journal of Laboratory and Clinical Medicine
Volume99
Issue number4
StatePublished - 1982
Externally publishedYes

Fingerprint

T-cells
Multiple Myeloma
B-Lymphocytes
Cells
T-Lymphocytes
T-Lymphocyte Subsets
Thymidine
Cell proliferation
Cell Proliferation
Agammaglobulinemia
Immunoglobulins
Pulse width modulation

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Enhanced T cell suppression is directed toward sensitive circulating B cells in multiple myeloma. / Perri, Robert T.; Oken, Martin M.; Kay, Neil Elliot.

In: The Journal of Laboratory and Clinical Medicine, Vol. 99, No. 4, 1982, p. 512-519.

Research output: Contribution to journalArticle

@article{3bb75ed0a92b466d80ebe21d14f873c3,
title = "Enhanced T cell suppression is directed toward sensitive circulating B cells in multiple myeloma",
abstract = "Multiple myeloma, a disorder typically accompanied by monoclonal immunoglobulin excess and hypogammaglobulinemia was evaluated to delineate the status of T cell regulation on malignant B cell proliferation. Intact T cells and T cell subsets previously noted by us to be suppressor (Tγ) and helper (T non-γ) were isolated from 10 controls and 10 myeloma patients. Various concentrations of control and patient T cell subsets were mixed with control and patient B cells and stimulated with PWM. T cell effect on B cell proliferation as measured by [3H]thymidine incorporation was then determined. Myeloma Tγ cells were more effective than control Tγ cells in suppressing control or myeloma B cell [3H]thymidine incorporation. Interestingly, myeloma B cells, when added to myeloma Tγ cells, were suppressed to a greater extent than were control B cells when mixed with a similar concentration of myeloma Tγ cells. These in vitro studies suggest a complexity of B and T cell abnormalities in multiple myeloma; first, the myeloma B cells are extremely sensitive to Tγ cell suppression, and second, myeloma Tγ cells have excessive suppressor capacity. It is yet unclear whether these results are associated with an immunoregulatory response to this malignancy or represent part of the basic disease process.",
author = "Perri, {Robert T.} and Oken, {Martin M.} and Kay, {Neil Elliot}",
year = "1982",
language = "English (US)",
volume = "99",
pages = "512--519",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Enhanced T cell suppression is directed toward sensitive circulating B cells in multiple myeloma

AU - Perri, Robert T.

AU - Oken, Martin M.

AU - Kay, Neil Elliot

PY - 1982

Y1 - 1982

N2 - Multiple myeloma, a disorder typically accompanied by monoclonal immunoglobulin excess and hypogammaglobulinemia was evaluated to delineate the status of T cell regulation on malignant B cell proliferation. Intact T cells and T cell subsets previously noted by us to be suppressor (Tγ) and helper (T non-γ) were isolated from 10 controls and 10 myeloma patients. Various concentrations of control and patient T cell subsets were mixed with control and patient B cells and stimulated with PWM. T cell effect on B cell proliferation as measured by [3H]thymidine incorporation was then determined. Myeloma Tγ cells were more effective than control Tγ cells in suppressing control or myeloma B cell [3H]thymidine incorporation. Interestingly, myeloma B cells, when added to myeloma Tγ cells, were suppressed to a greater extent than were control B cells when mixed with a similar concentration of myeloma Tγ cells. These in vitro studies suggest a complexity of B and T cell abnormalities in multiple myeloma; first, the myeloma B cells are extremely sensitive to Tγ cell suppression, and second, myeloma Tγ cells have excessive suppressor capacity. It is yet unclear whether these results are associated with an immunoregulatory response to this malignancy or represent part of the basic disease process.

AB - Multiple myeloma, a disorder typically accompanied by monoclonal immunoglobulin excess and hypogammaglobulinemia was evaluated to delineate the status of T cell regulation on malignant B cell proliferation. Intact T cells and T cell subsets previously noted by us to be suppressor (Tγ) and helper (T non-γ) were isolated from 10 controls and 10 myeloma patients. Various concentrations of control and patient T cell subsets were mixed with control and patient B cells and stimulated with PWM. T cell effect on B cell proliferation as measured by [3H]thymidine incorporation was then determined. Myeloma Tγ cells were more effective than control Tγ cells in suppressing control or myeloma B cell [3H]thymidine incorporation. Interestingly, myeloma B cells, when added to myeloma Tγ cells, were suppressed to a greater extent than were control B cells when mixed with a similar concentration of myeloma Tγ cells. These in vitro studies suggest a complexity of B and T cell abnormalities in multiple myeloma; first, the myeloma B cells are extremely sensitive to Tγ cell suppression, and second, myeloma Tγ cells have excessive suppressor capacity. It is yet unclear whether these results are associated with an immunoregulatory response to this malignancy or represent part of the basic disease process.

UR - http://www.scopus.com/inward/record.url?scp=0019974188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019974188&partnerID=8YFLogxK

M3 - Article

C2 - 6460827

AN - SCOPUS:0019974188

VL - 99

SP - 512

EP - 519

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 4

ER -